ER−/HER2+ | ER+/HER2+ | ER+/HER2− | TN | |
---|---|---|---|---|
Percent of patients | ||||
White | 18 (11%) | 39 (24%) | 51 (32%) | 49 (31%) |
Black | 42 (16%) | 39 (15%)a | 61 (23%)a | 109 (41%)a |
Percent with pCR | ||||
White | 9 (50%) | 9 (23%) | 6 (12%)b | 14 (29%) |
Black | 23 (55%) | 8 (21%)b | 4 (7%)b | 34 (31%)b |
Percent of patients | ||||
Hispanic | 24 (14%) | 33 (17%) | 54 (24%) | 48 (40%) |
Non-Hispanic | 45 (14%) | 54 (17%) | 76 (24%) | 123 (40%) |
Percent with pCR | ||||
Hispanic | 14 (58%) | 6 (18%)b | 7 (13%)b | 17 (35%) |
Non-Hispanic | 25 (55%) | 14 (26%) | 4 (5%)b | 36 (29%) |